JHL Biotech Opens Innovative Biosimilars Manufacturing Facility in China
CHALFONT ST. GILES, UK and WUHAN, CHINA – 10 May 2016 –JHL Biotech (JHL), a biopharmaceutical company, opened the world’s first KUBio™ biopharmaceutical manufacturing facility with single-use bioprocessing technology at a ribbon-cutting ceremony in Wuhan, China today. JHL will use the KUBio manufacturing solution delivered by GE Healthcare to manufacture biosimilars(1) and monoclonal antibodies (mAbs)... Read more